21 May 2013
Keywords: european, commission, clears, sanofi, msd/merck, co, zostavax
Article | 05 June 2006
The European Commission has granted a marketing authorization for Zostavax, an injection indicated for prevention of herpes zoster and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 June 2006
12 June 2006
20 May 2013
© 2013 thepharmaletter.com